Immunological studies on a hamster‐specific sarcoma virus
R. Bomford
Abstract
R. Bomford
Abstract
Abstract A hamster‐specific sarcoma virus released from cells of a Harvey murine sarcoma virus (H‐MSV)‐induced hamster tumour is shown to have the hamster leukaemia virus group‐specific (gs) antigen, and hence to be a hamster leukaemia virirs (HaL V) pseudotype of the murine sarcoma virus, H‐MSV (HaLV). The hamster leukaemia virus gs antigen is not detectable in non‐producer H‐MSV (HaLV) transformed hamster cells or in Rous sarcoma virus, polyoma or SV40‐transformed cells. Five out of 6 transplanted hamster tumours were found to contain the HaLV gs antigen.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract A hamster‐specific sarcoma virus released from cells of a Harvey murine sarcoma virus (H‐MSV)‐induced hamster tumour is shown to have the hamster leukaemia virus group‐specific (gs) antigen, and hence to be a hamster leukaemia virirs (HaL V) pseudotype of the murine sarcoma virus, H‐MSV (HaLV). The hamster leukaemia virus gs antigen is not detectable in non‐producer H‐MSV (HaLV) transformed hamster cells or in Rous sarcoma virus, polyoma or SV40‐transformed cells. Five out of 6 transplanted hamster tumours were found to contain the HaLV gs antigen.
Key concepts: Hamster, Rous sarcoma virus, Virology, Biology, Virus, Sarcoma, Antigen, Mesocricetus